Newsbenzinga
ANI Pharmaceuticals Says Phase 4 ILUVIEN Trial In Chronic Posterior Uveitis Met Co-Primary Endpoints, Results Maintained At 24 Months
· Published
Article summary
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…